Ascensia Diabetes Care
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Ascensia Diabetes Care sits in the top decile of US sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count).
Ascensia Diabetes Care: 42 sponsored US clinical trials, none currently recruiting.
Ascensia Diabetes Care sponsors 42 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 42 completed. The most-studied condition in this pipeline is Diabetes, with 6 trials.
Top-decile sponsor footprint
Ascensia Diabetes Care ranks in the top decile of sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
42 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
42 total, page 1 of 1
Ketostix® and Keto-Diastix® Performance Study
NCT06053593
Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples
NCT05467345
User Performance of the TV4 BGMS
NCT05647824
Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus
NCT04033315
User Performance of the Thunder Plus BGMS
NCT04008836
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
NCT03730480
Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System
NCT03165110
Evaluation of an Ascensia Lancing System
NCT02606838
Evaluation of an Ascensia Blood Glucose Meter and App System
NCT02568384
Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System
NCT02390167
Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System
NCT02371876
Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)
NCT02150109
Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System
NCT02041286
Evaluation of an Karajishi TS Investigational Blood Glucose Monitoring System
NCT02041377
Evaluation of an Investigational Blood Glucose Monitoring System
NCT01859494
Performance of an Investigational Blood Glucose Monitoring System
NCT01824355
Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates
NCT01756274
Evaluation of Blood Glucose Meter Systems
NCT01714232
Evaluation of Blood Glucose Monitoring Systems
NCT01699763
Performance Evaluation of an Investigational Blood Glucose Monitoring System
NCT01598610
Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting
NCT01614613
Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design
NCT01575080
Comparison Evaluation of Blood Glucose Meter Systems
NCT01548885
Study of an Investigational Glucose Meter System
NCT01466075
Study of an Investigational Glucose Meter System
NCT01474317
Blood Glucose Testing and You
NCT01453413
User Study of an Investigational Blood Glucose Monitoring System
NCT01447121
User Performance Evaluation of an Investigational Blood Glucose Monitoring System
NCT01410773
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting
NCT01268267
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial
NCT01328717
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting
NCT01268488
Performance of a New Glucose Meter System
NCT01264016
Performance of a New Glucose Meter System in Children and Young Adults
NCT00985257
Evaluation of DIDGET TM World Reports
NCT00923975
Evaluation of GLUCOFACTS® Deluxe Diabetes Management System
NCT00892151
Evaluation of Labeling Comprehension and Performance of a New Blood Glucose Meter System
NCT00804596
In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System
NCT00803777
Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood
NCT00797563
A New Glucose Meter With Alternative Site Testing
NCT00797212
Evaluation of the A1CNow+ Test Kit
NCT00798486
Glucose Meter Study
NCT00782496
Evaluation of a Diabetes Data Management System
NCT00694070
Therapeutic Areas
How the Ascensia Diabetes Care archive is shaped
42 indexed studies, none listed as recruiting (0% open); 42 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Diabetes (6 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Ascensia Diabetes Care: archived-pipeline peers nationwide
Peers matched on 42 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Ascensia Diabetes Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 42 archived trials
- Academic and Community Cancer Research United · 42 trials · 14% recruiting
- Avid Radiopharmaceuticals · 42 trials · 0% recruiting
- Celldex Therapeutics · 42 trials · 7% recruiting
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 42 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Ascensia Diabetes Care page
42 registered trials is a research-attention snapshot, not an endorsement of Ascensia Diabetes Care or any single study.
- None of Ascensia Diabetes Care's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Diabetes is the condition Ascensia Diabetes Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ascensia Diabetes Care pipeline card: 42 registered trials from official public datasets.Report a data error.